Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
283.2 GBX | +8.94% | +30.81% | +27.83% |
Apr. 29 | FTSE 100 as investors look to Fed rate decision | AN |
Apr. 29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.83% | 326M | |
-2.92% | 102B | |
+1.73% | 96.29B | |
+2.07% | 22.18B | |
-15.54% | 21.2B | |
-9.07% | 18.31B | |
-38.74% | 17.38B | |
-13.93% | 16.36B | |
+6.10% | 13.97B | |
+34.43% | 12.17B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition